[Intra-arterial infusion of antineoplastic agents in the treatment of urogenital cancer].
Reports of intra-arterial infusion chemotherapy for carcinomas were reviewed and the role of intra-arterial chemotherapy was discussed. Thirty-four patients with urogenital cancers, 27 of bladder transitional cell carcinoma, 5 of renal cell carcinoma and 2 of prostatic adenocarcinoma, were treated with adriamycin artery infusion and the pathological evaluation was performed. A response rate of the treatment for bladder cancer was 50.0%.
D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007261:Infusions, Intra-Arterial / Q000379:methods; D007680:Kidney Neoplasms / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D011471:Prostatic Neoplasms / Q000188:drug therapy; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy; D014571:Urologic Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents